Stock listing

NASDAQ:ORMP Oramed Pharmaceuticals Inc. Stock

Home listing (NASDAQ) of Oramed Pharmaceuticals Inc.

Follow Oramed Pharmaceuticals Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ORMP

$3.57 USD -0.32 (-8.2%)

Close on Nov 20, 2026

Past year +47.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$3.54 – $3.71 USDNov 20, 2026
Volume
285,666 sharesNov 20, 2026
Market cap
$155.2M USDAt the close on Nov 20, 2026 · price × 43.49M shares outstanding
52-week range
$2.40 – $5.47 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$774,468 USDMedian day 135,000 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Oramed Pharmaceuticals Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ORMP · Home$3.57 USD-0.32 (-8.2%)285,666$3.67$3.71$3.544$3.89Close on Nov 20, 2026
TASE:ORMP1,248.00 ILA (agorot)-6.00 (-0.5%)2,0061,254.001,266.001,241.001,254.00Close on Nov 19, 2026
Frankfurt:OJU1€3.31 EUR-0.185 (-5.3%)—€3.31€3.31€3.31€3.495Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ORMP · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$3.57-0.32-8.2%$3.67$3.71$3.544285,666
$3.89+0.02+0.5%$3.87$3.93$3.83164,339
$3.87-0.03-0.8%$3.85$3.96$3.85186,347
$3.90+0.19+5.1%$3.70$4.052$3.70346,559
$3.71-0.32-7.9%$4.03$4.12$3.67160,813
$4.03-0.10-2.4%$4.17$4.218$3.94111,223
$4.13+0.16+4.0%$3.99$4.14$3.99105,444
$3.97-0.03-0.7%$3.96$3.99$3.8680,664
$4.00+0.14+3.6%$3.94$4.025$3.85112,995
$3.86-0.03-0.8%$3.90$4.00$3.84112,539
$3.89-0.24-5.8%$4.08$4.08$3.89189,333
$4.13+0.13+3.2%$4.05$4.14$4.05119,675
$4.000.000.0%$4.02$4.05$3.915116,549
$4.00-0.11-2.7%$4.11$4.11$4.0097,259
$4.11-0.12-2.8%$4.22$4.29$4.0891,505
$4.23+0.07+1.7%$4.16$4.29$4.1691,006
$4.160.000.0%$4.10$4.17$4.1055,699
$4.16+0.08+2.0%$4.10$4.17$4.0697,228
$4.08-0.05-1.2%$4.14$4.20$4.04109,117
$4.13+0.01+0.2%$4.10$4.17$4.06115,700
$4.12-0.02-0.5%$4.09$4.21$4.0897,600
$4.14-0.01-0.2%$4.16$4.21$4.0684,400
$4.15+0.09+2.2%$4.06$4.22$4.05142,300
$4.06-0.01-0.2%$4.08$4.10$3.89162,700
$4.07-0.11-2.6%$4.19$4.19$3.99277,100
$4.18+0.04+1.0%$4.18$4.28$4.15128,200
$4.14-0.03-0.7%$4.12$4.22$4.12146,600
$4.17-0.10-2.3%$4.28$4.28$4.15113,800
$4.27-0.06-1.4%$4.34$4.35$4.2173,200
$4.33+0.13+3.1%$4.17$4.34$4.15193,500
$4.20-0.17-3.9%$4.36$4.36$4.16166,500
$4.37-0.01-0.2%$4.43$4.45$4.3584,700
$4.38-0.17-3.7%$4.55$4.58$4.3696,200
$4.55+0.06+1.3%$4.50$4.57$4.43104,100
$4.49+0.01+0.2%$4.53$4.57$4.39178,300
$4.48-0.19-4.1%$4.65$4.69$4.43272,600
$4.67-0.02-0.4%$4.70$4.72$4.66129,200
$4.69-0.06-1.3%$4.76$4.80$4.67170,700
$4.75+0.02+0.4%$4.70$4.78$4.65110,400
$4.73-0.06-1.3%$4.80$4.90$4.72177,900
$4.79+0.07+1.5%$4.71$4.88$4.65149,300
$4.72-0.03-0.6%$4.74$4.74$4.62134,800
$4.75+0.05+1.1%$4.71$4.84$4.71145,200
$4.70-0.04-0.8%$4.76$4.76$4.6797,400
$4.74+0.07+1.5%$4.65$4.80$4.61804,600
$4.67+0.05+1.1%$4.70$4.77$4.65128,000
$4.620.000.0%$4.63$4.67$4.54122,800
$4.62-0.05-1.1%$4.64$4.66$4.55142,800
$4.67+0.01+0.2%$4.64$4.76$4.64135,000
$4.66-0.10-2.1%$4.81$4.82$4.65144,500
$4.76-0.02-0.4%$4.74$4.85$4.66131,500
$4.78-0.20-4.0%$4.94$4.94$4.70244,800
$4.98-0.03-0.6%$4.99$5.01$4.92118,200
$5.01+0.08+1.6%$4.92$5.05$4.86226,900
$4.93-0.14-2.8%$5.11$5.11$4.81188,000
$5.07+0.22+4.5%$4.85$5.15$4.85188,600
$4.85-0.17-3.4%$5.00$5.15$4.80255,300
$5.02-0.01-0.2%$5.03$5.06$4.90242,900
$5.03-0.07-1.4%$5.14$5.15$5.01154,100
$5.10-0.24-4.5%$5.35$5.47$5.06276,300
$5.34+0.13+2.5%$5.31$5.43$5.12400,500
$5.21+0.39+8.1%$4.80$5.25$4.80641,500
$4.82+0.01+0.2%$4.80$4.86$4.7490,700
$4.81+0.02+0.4%$4.81$4.88$4.75126,100
$4.790.000.0%$4.78$4.86$4.68177,200

Splits

1 split · NASDAQ:ORMP · every price before a split is adjusted for it

DayRatioWhat
1-for-12Consolidation
Ticker
NASDAQ:ORMP
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Oramed Pharmaceuticals Inc. news

Oramed Pharmaceuticals Inc. on 6ix

News releases
4 in the last 12 months · 129 in all · newest Jun 25, 2026 · oldest 2019
Decks
36 decks · latest August 2023

Where Oramed Pharmaceuticals Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ORMP · Home listing · This pageNASDAQUnited StatesUSD
TASE:ORMPTASEIsraelILA
Tradegate:OJU1TradegateGermanyEUR
Lang & Schwarz:A1CTNULang & SchwarzGermanyEUR
LS Exchange:A1CTNULS ExchangeGermanyEUR
Frankfurt:OJU1FrankfurtGermanyEUR
BOATS:ORMPBOATSUnited StatesUSD
gettex:OJU1gettexGermanyEUR
Dusseldorf:OJU1DusseldorfGermanyEUR
Munich:OJU1MunichGermanyEUR
Stuttgart:OJU1StuttgartGermanyEUR

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$127.3M USD
P/E
1.1×
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.5×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.21

Forecasts

Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
7.00 USD · Analysts' mean
EPS, year to Dec 2026
4.47 · 1 analyst

Team and board

OfficerRole
Arie MayerManaging Director and Chairman of the Board

Events

QuarterResultsShare move
Q3 2026Nov 12, 2026 · After close−7.9%
Q2 2026Aug 10, 2026 · After close+1.2%
Q1 2026Jun 3, 2026+5.8%
Q4 2025Mar 26, 2026 · After close−0.3%
Q3 2025Nov 13, 2025 · After close−2.9%
Q2 2025Aug 14, 2025 · After close−1.9%
Q1 2025May 15, 2025 · After close−2.3%
Q4 2024Mar 4, 2025 · After close+7.5%
Q3 2024Nov 7, 2024 · After close−2.9%
Q2 2024Aug 14, 2024 · After close+4.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close+0.8%
Q4 2023Mar 6, 2024 · After close−0.3%
Q3 2023Nov 9, 2023 · After close−1.5%
Q2 2023Aug 10, 2023 · After close+2.5%
Q1 2023May 11, 2023 · After close+0.3%
Q4 2022Mar 6, 2023 · After close0.0%
Q3 2022Nov 10, 2022 · After close+14.7%
Q2 2022Aug 10, 2022 · After close+8.8%
Q1 2022May 12, 2022 · After close+10.4%
Q4 2021Jan 11, 2022 · After close+0.3%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2023)Investor deck41 slidesAugust 2023
Investor Presentation (May 2023)Investor deck41 slidesMay 2023
Investor Presentation (December 2022)Investor deck42 slidesDecember 2022
Investor Presentation (December 2022)Investor deck41 slidesDecember 2022
Oramed NASH Webinar: Phase 2 Trial Results of ORMD-0801 (November 2022)Conference29 slidesNov 17, 2022
Investor Presentation (August 2022)Investor deck40 slidesAugust 2022
Investor Presentation (June 2022)Investor deck40 slidesJune 2022
Technical Presentation (June 2022)Technical22 slidesJune 2022
Investor Presentation (March 2022)Investor deck40 slidesMarch 2022
Investor Presentation (December 2021)Investor deck38 slidesDec 7, 2021
All 36 decks
DeckKindSlidesDate
Investor Presentation (September 2021)Investor deck37 slidesSeptember 2021
Investor Presentation (August 2021)Investor deck36 slidesAugust 2021
Investor Presentation (March 2021)Investor deck43 slidesMar 19, 2021
Investor Presentation (October 2020)Investor deck42 slidesOct 22, 2020
EASD 2020Conference14 slidesSeptember 2020
EASD 2020Conference14 slides2020
Investor Presentation (November 2019)Investor deck37 slidesNov 18, 2019
Investor Presentation (April 2019)Investor deck44 slidesApril 2019
Investor Presentation (February 2019)Investor deck44 slidesFebruary 2019
Investor Presentation (December 2018)Investor deck44 slidesDecember 2018
Investor Presentation (August 2018)Investor deck44 slidesAugust 2018
Investor Presentation (June 2017)Investor deck38 slidesJune 2017
Technical Presentation (July 2016)Technical10 slidesJul 28, 2016
Technical Presentation (July 2016)Technical10 slidesJul 28, 2016
Investor Presentation (May 2016)Investor deck35 slidesMay 23, 2016
Investor Presentation (May 2016)Investor deck34 slidesMay 2016
Investor Presentation (January 2016)Investor deck34 slidesJan 14, 2016
Investor Presentation (July 2015)Investor deck38 slidesJuly 2015
Investor Presentation (December 2014)Investor deck40 slidesDec 2, 2014
Technical Presentation (November 2014)Technical11 slidesNov 3, 2014
Investor Presentation (September 2014)Investor deck35 slidesSep 8, 2014
GTC Diabetes Summit (April 2014)Conference21 slidesApr 24, 2014
Investor Presentation (February 2014)Investor deck41 slidesFeb 12, 2014
IPO Roadshow (June 2013)IPO roadshow42 slidesJun 17, 2013
Investor Presentation (September 2010)Investor deck14 slidesSep 8, 2010
Investor Presentation (July 2008)Investor deck19 slidesJul 23, 2008

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2021FY2020FY2020FY2019FY2019
Revenue2.00M01.34M2.70M2.70M2.70M2.71M2.71M2.70M2.70M
Cost of revenue1.99M193.0K90.0K90.0K90.0K
Gross profit13.0K-193.0K1.34M2.70M2.70M2.71M2.61M2.61M
Research and development6.38M6.32M8.97M27.6M21.0M21.0M10.2M10.2M13.5M13.5M
Selling, general and administrative8.72M6.46M8.43M13.8M5.94M4.23M3.72M
Operating income-15.1M-12.8M-15.8M-40.6M-24.2M-24.2M-11.8M-11.8M-14.6M-14.6M
Depreciation and amortization121.0K193.0K196.0K58.0K77.0K77.0K7.00K7.00K8.00K8.00K
EBITDA-15.0M-12.6M-15.6M-40.5M-24.1M-24.1M-11.8M-11.8M-14.6M-14.6M
Interest expense0853.0K2.04M2.93M6.00K126.0K
Income before tax75.3M-15.9M5.09M-37.7M-23.0M5.31M-11.5M-11.5M-14.1M-14.1M
Income tax11.3M3.18M100.0K-2.88M192.0K300.0K300.0K
Net income64.0M-19.1M5.09M-36.6M-22.2M-23.0M-11.5M-11.5M-14.4M-14.4M
Earnings per share, basic1.53-0.480.14-0.94-0.780.78-0.560.56-0.820.82
Earnings per share, diluted1.50-0.480.14-0.940.780.560.82

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2021FY2020FY2020FY2019FY2019
Cash and equivalents45.9M54.4M9.05M40.5M77.2M77.2M19.3M19.3M3.33M3.33M
Short-term investments5.42M3.44M57.7M3.74M16.9M5.85M20.6M3.30M29.0M3.70M
Receivables4.64M
Current assets133.3M143.2M162.6M157.1M95.3M95.3M40.5M40.5M33.3M33.3M
Property, plant and equipment586.0K698.0K873.0K815.0K397.0K99.0K24.0K
Total assets230.9M155.3M220.6M161.6M128.0M128.0M44.6M44.6M34.7M34.7M
Accounts payable443.0K789.0K551.0K2.17M2.61M594.0K1.34M
Current liabilities19.1M5.68M53.2M5.75M6.68M6.68M4.54M4.54M5.31M5.31M
Total debt825.0K372.0K51.6M25.0K533.0K12.5M75.0K12.4M
Total liabilities31.1M9.93M57.7M10.5M11.5M11.8M15.3M
Shareholders' equity199.7M146.3M163.8M151.8M115.8M115.8M32.9M32.9M19.4M19.4M
Shares outstanding39.3M39.9M40.3M39.6M28.5M35.3M20.5M23.7M17.5M17.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2021FY2020FY2020FY2019FY2019
Cash from operations-9.14M-8.41M-10.3M-27.9M-21.2M-21.2M-12.4M-12.4M-12.9M-12.9M
Capital spending-9.00K-18.0K-254.0K-496.0K-375.0K-375.0K-82.0K-82.0K-15.0K-15.0K
Free cash flow-9.15M-8.43M-10.5M-28.4M-21.6M-21.6M-12.5M-12.5M-13.0M-13.0M
Cash from investing5.44M105.8M-73.0M30.2M-22.3M-23.8M4.63M4.63M11.3M11.3M
Cash from financing-4.74M-52.0M52.0M10.8M101.4M102.9M23.8M23.8M
Dividends paid-10.9M
Share buybacks-4.74M-2.48M0
Change in cash-8.47M45.4M-31.4M13.0M57.9M57.9M16.0M16.0M-1.67M-1.67M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 19, 2026Current reportSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
144 · Notice of proposed saleOct 1, 2026Other filingsSEC
144 · Notice of proposed saleOct 1, 2026Other filingsSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
8-K · Current reportSep 17, 2026Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 10, 2026Quarterly reportSEC
ARS · Annual report to shareholdersAug 3, 2026Annual reportSEC
DEFA14A · Additional proxy materialAug 3, 2026Meeting noticeSEC
DEF 14A · Proxy statementAug 3, 2026Meeting noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 22, 2026Big-stake noticeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
144 · Notice of proposed saleJul 1, 2026Other filingsSEC
144 · Notice of proposed saleJul 1, 2026Other filingsSEC
8-K · Current reportJun 30, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedJun 29, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 17, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 19, 2026Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2026Explanation requestSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
3 · Initial statement of ownershipMay 14, 2026Insider tradeSEC
SCHEDULE 13D · Big-stake noticeMay 14, 2026Big-stake noticeSEC
8-K · Current reportMar 31, 2026Acquisition or disposalSEC
4 · Change in ownershipMar 31, 2026Insider tradeSEC
4 · Change in ownershipMar 31, 2026Insider tradeSEC
10-K · Annual reportMar 26, 2026Annual reportSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
8-K · Current reportFeb 20, 2026Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 19, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 9, 2026Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeJan 29, 2026Big-stake noticeSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
8-K · Current reportJan 14, 2026Material contractSEC
8-K · Current reportJan 7, 2026Current reportSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 2, 2026Insider tradeSEC
4 · Change in ownershipJan 2, 2026Insider tradeSEC
8-K · Current reportDec 31, 2025Management or board changeSEC
8-K · Current reportDec 30, 2025Current reportSEC
8-K · Current reportNov 17, 2025ResultsSEC
8-A12B · Registration of shares for listing on an exchangeNov 17, 2025Other filingsSEC
8-K · Current reportNov 17, 2025Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportOct 23, 2025ResultsSEC
8-K · Current reportOct 6, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedAug 28, 2025Big-stake noticeSEC
S-8 · Registration statement for employee plansAug 21, 2025Offer documentSEC
8-K · Current reportAug 21, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportJul 23, 2025Material contractSEC
ARS · Annual report to shareholdersJul 16, 2025Annual reportSEC
DEF 14A · Proxy statementJul 16, 2025Meeting noticeSEC
10-K/A · Annual report, amendedJul 16, 2025Annual reportSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
8-K · Current reportMay 21, 2025Current reportSEC
10-Q · Quarterly reportMay 15, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 8, 2025Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeMay 1, 2025Big-stake noticeSEC
8-K · Current reportApr 28, 2025Material contractSEC
10-K · Annual reportMar 27, 2025Annual reportSEC
8-K · Current reportMar 3, 2025Material contractSEC
8-K · Current reportFeb 27, 2025Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2025Big-stake noticeSEC
8-K · Current reportFeb 11, 2025Material contractSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC
8-K · Current reportJan 22, 2025Material contractSEC
SCHEDULE 13G · Big-stake noticeJan 17, 2025Big-stake noticeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
8-K · Current reportJan 3, 2025Material contractSEC
8-K · Current reportDec 17, 2024Current reportSEC
4 · Change in ownershipNov 8, 2024Insider tradeSEC
4 · Change in ownershipNov 8, 2024Insider tradeSEC
4 · Change in ownershipNov 8, 2024Insider tradeSEC
4 · Change in ownershipNov 8, 2024Insider tradeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
8-K · Current reportOct 29, 2024Current reportSEC
8-K · Current reportOct 8, 2024Material contractSEC
8-K · Current reportSep 26, 2024Material contractSEC
8-K · Current reportSep 23, 2024Current reportSEC
SC 13G · Big-stake noticeSep 16, 2024Big-stake noticeSEC
10-Q · Quarterly reportAug 14, 2024Quarterly reportSEC
8-K · Current reportAug 2, 2024Meeting outcomeSEC
8-K · Current reportJun 26, 2024Current reportSEC
8-K · Current reportJun 24, 2024Current reportSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
3 · Initial statement of ownershipJun 21, 2024Insider tradeSEC
ARS · Annual report to shareholdersJun 20, 2024Annual reportSEC
DEF 14A · Proxy statementJun 20, 2024Meeting noticeSEC
8-K · Current reportJun 10, 2024Management or board changeSEC
4 · Change in ownershipJun 10, 2024Insider tradeSEC
8-K · Current reportMay 10, 2024Management or board changeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
8-K · Current reportMay 6, 2024Current reportSEC
4 · Change in ownershipApr 18, 2024Insider tradeSEC
3 · Initial statement of ownershipApr 2, 2024Insider tradeSEC
SC 13D · Big-stake noticeMar 22, 2024Big-stake noticeSEC
8-K · Current reportMar 19, 2024Current reportSEC
8-K · Current reportMar 18, 2024Management or board changeSEC
8-K · Current reportMar 18, 2024Material contractSEC
424B5 · ProspectusMar 18, 2024Offer documentSEC
10-K · Annual reportMar 6, 2024Annual reportSEC
8-K · Current reportFeb 20, 2024Current reportSEC
4 · Change in ownershipJan 30, 2024Insider tradeSEC
8-K · Current reportJan 23, 2024Material contractSEC
8-K · Current reportJan 19, 2024Management or board changeSEC
4 · Change in ownershipJan 8, 2024Insider tradeSEC
4 · Change in ownershipJan 8, 2024Insider tradeSEC
4 · Change in ownershipJan 8, 2024Insider tradeSEC
4 · Change in ownershipJan 8, 2024Insider tradeSEC
4 · Change in ownershipJan 8, 2024Insider tradeSEC
4 · Change in ownershipJan 8, 2024Insider tradeSEC
4 · Change in ownershipJan 8, 2024Insider tradeSEC
4 · Change in ownershipJan 8, 2024Insider tradeSEC
4 · Change in ownershipJan 8, 2024Insider tradeSEC
3 · Initial statement of ownershipJan 2, 2024Insider tradeSEC
8-K · Current reportDec 21, 2023Current reportSEC
8-K · Current reportDec 18, 2023Management or board changeSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
8-K · Current reportSep 26, 2023Material contractSEC
8-K · Current reportSep 13, 2023Current reportSEC
8-K · Current reportAug 21, 2023Material contractSEC
10-Q · Quarterly reportAug 10, 2023Quarterly reportSEC
8-K · Current reportAug 9, 2023Material contractSEC
8-K · Current reportAug 7, 2023Current reportSEC
8-K · Current reportJul 13, 2023Meeting outcomeSEC
ARS · Annual report to shareholdersMay 31, 2023Annual reportSEC
DEF 14A · Proxy statementMay 31, 2023Meeting noticeSEC
4 · Change in ownershipMay 31, 2023Insider tradeSEC
4 · Change in ownershipMay 31, 2023Insider tradeSEC
4 · Change in ownershipMay 31, 2023Insider tradeSEC
4 · Change in ownershipMay 31, 2023Insider tradeSEC
4 · Change in ownershipMay 31, 2023Insider tradeSEC
10-Q · Quarterly reportMay 11, 2023Quarterly reportSEC
4 · Change in ownershipMay 1, 2023Insider tradeSEC
3 · Initial statement of ownershipMay 1, 2023Insider tradeSEC
8-K · Current reportMay 1, 2023Management or board changeSEC
4 · Change in ownershipApr 20, 2023Insider tradeSEC
4 · Change in ownershipApr 20, 2023Insider tradeSEC
4 · Change in ownershipApr 20, 2023Insider tradeSEC
4 · Change in ownershipApr 20, 2023Insider tradeSEC
4 · Change in ownershipApr 20, 2023Insider tradeSEC
4 · Change in ownershipApr 20, 2023Insider tradeSEC
4 · Change in ownershipApr 20, 2023Insider tradeSEC
4 · Change in ownershipApr 20, 2023Insider tradeSEC
4 · Change in ownershipApr 4, 2023Insider tradeSEC
4 · Change in ownershipMar 16, 2023Insider tradeSEC
4 · Change in ownershipMar 15, 2023Insider tradeSEC
4 · Change in ownershipMar 15, 2023Insider tradeSEC
4 · Change in ownershipMar 15, 2023Insider tradeSEC
10-K · Annual reportMar 6, 2023Annual reportSEC
8-K · Current reportFeb 27, 2023Current reportSEC
8-K · Current reportJan 11, 2023Current reportSEC
4 · Change in ownershipJan 4, 2023Insider tradeSEC
8-K · Current reportDec 12, 2022Current reportSEC
8-K · Current reportNov 14, 2022Current reportSEC
8-K · Current reportNov 10, 2022ResultsSEC
10-Q · Quarterly reportNov 10, 2022Quarterly reportSEC
4 · Change in ownershipOct 28, 2022Insider tradeSEC

This page holds 200 of 952 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Oramed Pharmaceuticals Inc.’s releases · as of Nov 11, 2026

Common shares
43,485,942
Fully diluted
43,485,942

Fully diluted

LineSharesAs of
Common shares43,485,942Nov 11, 2026

Share count over time

CountShares
Nov 11, 202643,485,942

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Mercer Global Advisors Inc3.81M8.8%US$17.8MSep 30, 2026
Aquamarine Financial (Cayman) Ltd2.65M6.1%US$12.4MSep 30, 2026
Murchinson Ltd.2.14M4.9%US$10MSep 30, 2026
Gem Investment Advisors, LLC2M4.6%US$9.33MSep 30, 2026
BlackRock1.84M4.2%US$8.59MSep 30, 2026
BML Capital Management, LLC884K2.0%US$4.13MSep 30, 2026
Boothbay Fund Management, LLC821K1.9%US$3.83MSep 30, 2026
Geode Capital501K1.2%US$2.34MSep 30, 2026
State Street467K1.1%US$2.18MSep 30, 2026
Renaissance Technologies294K0.68%US$1.37MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard254K0.58%US$1.18MSep 30, 2026
Rathbones Group PLC233K0.54%US$1.09MSep 30, 2026
Dimensional211K0.49%US$987KSep 30, 2026
Strs Ohio189K0.43%US$880KSep 30, 2026
Northern Trust179K0.41%US$834KSep 30, 2026
Bank of America162K0.37%US$758KSep 30, 2026
Two Sigma160K0.37%US$747KSep 30, 2026
Wells Fargo145K0.33%US$679KSep 30, 2026
Morgan Stanley108K0.25%US$504KSep 30, 2026
UBS97,6730.22%US$456KSep 30, 2026
Schwab83,6340.19%US$391KSep 30, 2026
BNY79,2550.18%US$370KSep 30, 2026
Segall Bryant & Hamill, LLC76,6440.18%US$358KSep 30, 2026
O'Shaughnessy Asset Management, LLC75,7720.17%US$313KSep 30, 2026
Ritholtz Wealth Management67,9390.16%US$317KSep 30, 2026
Goldman Sachs62,2930.14%US$291KSep 30, 2026
Citadel59,8440.14%US$279KSep 30, 2026
American Century59,7750.14%US$279KSep 30, 2026
Connor, Clark & Lunn Investment Management Ltd.52,8230.12%US$247KSep 30, 2026
Nuveen50,3710.12%US$235KSep 30, 2026
State Board Of Administration Of Florida Retirement System33,9740.08%US$159KSep 30, 2026
Bailard, Inc.32,4780.07%US$152KSep 30, 2026
Prudential Financial Inc32,4400.07%US$151KSep 30, 2026
DWS29,0600.07%US$136KSep 30, 2026
T. Rowe Price27,9090.06%US$131KSep 30, 2026
Rhumbline Advisers27,5980.06%US$129KSep 30, 2026
Jane Street27,0680.06%US$126KSep 30, 2026
Prelude Capital Management, LLC26,4410.06%US$123KSep 30, 2026
Invesco24,4630.06%US$114KSep 30, 2026
PNC Financial Services Group, Inc.23,5610.05%US$110KSep 30, 2026
Quadrature Capital Ltd22,5220.05%US$105KSep 30, 2026
MetLife Investment Management, LLC20,7430.05%US$96,870Sep 30, 2026
Squarepoint Ops LLC20,3530.05%US$95,049Sep 30, 2026
Engineers Gate Manager LP19,8520.05%US$92,709Sep 30, 2026
Sage Capital Management, LLC17,9770.04%US$83,957Sep 30, 2026
XTX Topco Ltd17,4020.04%US$81,267Sep 30, 2026
Redwood Family Wealth LLC17,0000.04%US$79,390Sep 30, 2026
JPMorgan16,6280.04%US$77,985Sep 30, 2026
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.16,4970.04%US$77,041Sep 30, 2026
Wealth Enhancement Advisory Services, LLC16,0420.04%US$67,376Sep 30, 2026

This page holds 50 of 89 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
iShares Russell 2000 ETF635K1.5%US$3.05MJun 30, 2026
Fidelity Small Cap Index Fund378K0.87%US$1.54MJul 31, 2026
iShares Russell 2000 Value ETF319K0.73%US$1.53MJun 30, 2026
iShares Micro-Cap ETF115K0.26%US$553KJun 30, 2026
Schwab Small-Cap Index Fund83,6340.19%US$340KJul 31, 2026
Master Small Cap Index Series63,6160.15%US$306KJun 30, 2026
Fidelity Small Cap Value Index Fund48,7470.11%US$234KJun 30, 2026
Nuveen Small Cap Blend Index Fund46,4040.11%US$189KJul 31, 2026
Dimensional U.S. Small Cap ETF40,4830.09%US$165KJul 31, 2026
Dimensional U.S. Core Equity 2 ETF36,5360.08%US$149KJul 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
EQ/2000 Managed Volatility Portfolio33,5450.08%US$161KJun 30, 2026
Nationwide Bailard Small Cap Value Fund32,4780.07%US$132KJul 31, 2026
Avantis U.S. Small Cap Equity ETF28,1550.06%US$112KMay 31, 2026
LVIP State Street Small-Cap Index Fund25,7000.06%US$124KJun 30, 2026
Fidelity Nasdaq Composite Index Fund24,2820.06%US$96,400May 31, 2026
U.S. Core Equity 2 Portfolio23,3490.05%US$95,030Jul 31, 2026
U.S. Small Cap Portfolio20,6320.05%US$83,972Jul 31, 2026
Global X Russell 2000 ETF16,2370.04%US$66,085Jul 31, 2026
Small Cap Index Fund15,9830.04%US$76,878Jun 30, 2026
U.S. Vector Equity Portfolio10,5810.02%US$43,065Jul 31, 2026
iShares Russell Small/Mid-Cap Index Fund9,6050.02%US$39,092Jul 31, 2026
Small-Cap Index Portfolio9,5830.02%US$46,094Jun 30, 2026
1290 VT Micro Cap Portfolio7,6640.02%US$36,864Jun 30, 2026
NVIT Small Cap Index Fund7,4840.02%US$35,998Jun 30, 2026
ATM Small Cap Managed Volatility Portfolio7,2660.02%US$34,949Jun 30, 2026
DWS Small Cap Index VIP5,3020.01%US$25,503Jun 30, 2026
T. Rowe Price Small-Cap Index Fund5,1310.01%US$24,680Jun 30, 2026
U.S. Social Core Equity 2 Portfolio4,9290.01%US$20,061Jul 31, 2026
JNL/DFA U.S. Small Cap Fund4,8700.01%US$23,425Jun 30, 2026
1290 VT Small Cap Value Portfolio4,6830.01%US$22,525Jun 30, 2026
BlackRock Small Cap Index V.I. Fund4,5710.01%US$21,987Jun 30, 2026
Dimensional US Core Equity 1 ETF4,5230.01%US$18,409Jul 31, 2026
Avantis U.S. Equity ETF4,152<0.01%US$16,483May 31, 2026
SA Small Cap Index Portfolio3,985<0.01%US$16,219Jul 31, 2026
Victory Extended Market Index Fund3,654<0.01%US$14,872Jul 31, 2026
Dimensional U.S. Equity Market ETF3,431<0.01%US$13,964Jul 31, 2026
U.S. Core Equity 1 Portfolio3,131<0.01%US$12,743Jul 31, 2026
CVT Russell 2000 Small Cap Index Portfolio3,088<0.01%US$14,853Jun 30, 2026
Nationwide Small Cap Index Fund2,926<0.01%US$11,909Jul 31, 2026
SmallCap Value Fund II2,771<0.01%US$11,278Jul 31, 2026
Venerable Small Cap Index Fund2,721<0.01%US$13,088Jun 30, 2026
LVIP Dimensional U.S. Core Equity 2 Fund2,680<0.01%US$12,891Jun 30, 2026
EQ/AB Small Cap Growth Portfolio2,100<0.01%US$10,101Jun 30, 2026
EQ/Small Company Index Portfolio2,100<0.01%US$10,101Jun 30, 2026
EQ/Franklin Small Cap Value Managed Volatility Portfolio1,309<0.01%US$6,296Jun 30, 2026
Penn Series Small Cap Index Fund1,000<0.01%US$4,810Jun 30, 2026
PD Small-Cap Value Index Portfolio990<0.01%US$4,762Jun 30, 2026
State Street Total Return V.I.S. Fund859<0.01%US$4,132Jun 30, 2026
Small-Cap Equity Portfolio564<0.01%US$2,713Jun 30, 2026
Ultra Small Cap Profund438<0.01%US$1,783Jul 31, 2026

This page holds 50 of 58 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Hexter Joshua
Officer: COO & CBO
Sale30,000USD 4.51US$135KOct 1, 2026
Gabay Avraham
Officer: Chief Financial Officer
Sale20,000USD 4.51US$90,200Oct 1, 2026
Gabay Avraham
Officer: Chief Financial Officer
Sale73,360USD 4.51US$331KJul 1, 2026
Hexter Joshua
Officer: COO & CBO
Sale137,000USD 4.46US$611KJul 1, 2026

Big stakes

StakeStakeSharesDateFiling
Nadav Kidron7.60%3.12MFeb 11, 2025Schedule 13D
Aquamarine Financial (Cayman) Ltd6.38%2.65MSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kevin Rakin
Other companies: Elutia, Inc. (Chairman · Since at least Oct 7, 2020); Quantum-Si Incorporated (Director · Since at least Sep 3, 2020); Ocugen, Inc. (Director · Dec 2, 2014 – Feb 8, 2019 · Past)
Director · Aug 30, 2016 – Mar 21, 2022 · Past
Nadav Kidron
Other companies: Nano Dimension Ltd (Director · Since at least Aug 16, 2026); Lifeward Ltd. (Director · Since at least Mar 25, 2026); Alpha Tau Medical Ltd (Director · Since at least May 12, 2025)
President and CEO, Director · Since at least Feb 3, 2006
Alex Weber
Other companies: Blue Sphere Corp (Chief Financial Officer · Apr 8, 2010 – Apr 8, 2010 · Past); Global Energy Holdings Group Inc (Treasurer & CFO · May 6, 2007 – May 6, 2007 · Past)
Treasurer & CFO · Aug 1, 2007 – Aug 1, 2007 · Past
Avraham Gabay
Other companies: Lifeward Ltd. (Director · Since at least Aug 20, 2026); BiomX Inc. (Interim CFO · Dec 6, 2023 – Dec 6, 2023 · Past)
Chief Financial Officer · Since at least Jun 18, 2024
David Silberman
Other companies: Compugen Ltd. (Chief Financial Officer · Since at least Mar 18, 2026); Nasus Pharma Ltd. (Board Member · Since at least Mar 18, 2026)
Chief Financial Officer · Jul 5, 2021 – Jan 4, 2024 · Past
Harold Jacob
Other companies: ENvue Medical, Inc. (Chief Medical Officer, Director · Apr 10, 2015 – Dec 30, 2024 · Past)
Director · Aug 8, 2012 – Mar 10, 2016 · Past
Joshua Hexter
Other companies: Lifeward Ltd. (Interim Chief Executive Officer · Since Sep 1, 2026 · Appointed, no departure found)
COO & CBO · Since at least Apr 14, 2013
Miriam Kidron
Other companies: Lifeward Ltd. (Director · Since at least Mar 25, 2026)
Chief Scientific Officer, Director · Since at least Dec 31, 2025
Ronald Edward Law
Other companies: BioSpecifics Technologies Corp (SVP Business Development · Jan 23, 2019 – Jan 23, 2019 · Past)
Chief Strategy Officer · Mar 20, 2017 – Mar 20, 2017 · Past
Yehuda Reznick
Other companies: Lifeward Ltd. (Director · Since at least Mar 25, 2026)
Director · Since at least Apr 1, 2024
All 19 people
PersonSeat
Arie MayerDirector · Since at least Jan 4, 2024
Benjamin ShapiroDirector · Since at least Jan 4, 2024
Daniel AghionDirector · Since at least Nov 12, 2026
David Mark SlagerDirector · Aug 30, 2016 – Apr 15, 2019 · Past
Leonard SankDirector · Since at least Oct 23, 2007
Mark Daniel HasletonVP Business Development · Nov 15, 2018 – Feb 26, 2019 · Past
Michael RabinowitzChief Commercial Officer · Aug 1, 2021 – Jan 3, 2023 · Past
Netanel DerovanChief Legal Officer · Jan 9, 2022 – May 26, 2023 · Past
Yifat Hen ZommerCFO, Treasurer and Secretary · Apr 19, 2009 – Jun 30, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about Oramed Pharmaceuticals Inc.